Orchid Pharma is a well-established and reputed company, listed in the Bombay stock exchange that has now re-entered the formulations business in India, with an initial focus on hospital segment. Orchid is the only Indian company to get USFDA approve manufacturing plant for Cephalosporins. We have launched a critical care division with focus on Injectable Antibiotics & Antifungals.